ReviewFrontiers in oncology2022

The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways.

Michael J Birrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.